BioSpace News Archive

Lyme Disease Setting Record in Number of Cases Every Year

Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the second quarter ended June 30, 2022 on Tuesday, August 2, 2022, after market close.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it will participate at the 30th Annual NNPDF Family Support & Medical Conference in conjunction with the INPDA Biennial Meeting.

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2022 financial results will be released on Thursday, August 4, 2022 after the market closes.

Nanomix Corporation today announced that it has entered into a distribution agreement with Biotron Ltd. (“Biotron”), an Israeli medical diagnostics distributor.

LabCentral today announced that Takeda, will become a LabCentral Founding Sponsor.

Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health.

Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2022 financial results on Thursday, August 4, 2022, after the financial markets close.

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its second quarter 2022 financial results after market close on August 4th , 2022.

PharmaCyte Biotech, Inc. announced today that it has commenced the pilot phase of its two-phase pig study.